TY  - JOUR
AU  - Lee, Rachael Chang
AU  - Thapa, Bibhusal
AU  - John, Thomas
PY  - 2018
TI  - LACES and bootstraps: the hunt for prognostic and predictive markers for adjuvant therapy in NSCLC
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - The benefit from adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC) is modest with an overall survival (OS) benefit of only ~5% demonstrated in the Lung Adjuvant Cisplatin Evaluation (LACE) meta-analysis (1).
UR  - https://tlcr.amegroups.org/article/view/24027